Elucidating CXCL13/CXCR5 signaling effects and downstream signaling pathways will help investigate the molecular mechanisms that control tumor progression and responses to targeted therapies, accelerating the translation of drug research into clinical precision medicine. Here, CXCL13 is linked to neoplasm.